series-c-plus
Stage
2
Investors
About
Alector develops therapies for neurodegenerative diseases using proprietary brain delivery technology to cross the blood-brain barrier and target underlying disease drivers.
Explore Alector's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.